Roche Diagnostics NT-proBNP As a Marker for Emergency Diagnosis.Business Editors/Health/Medical Writers BASEL, Switzerland--(BUSINESS WIRE)--Aug. 26, 2003 Elecsys(R) proBNP from Roche Diagnostics is the world's first fully-automated biochemical laboratory test for heart failure. The test facilitates the early diagnosis of heart failure. An elevated concentration of NT-proBNP (N-terminal pro-Brain Natriuretic Peptide) in the blood indicates the presence of ventricular dysfunction ventricular dysfunction, n an abnormality in contraction and wall motion within the ventricles. and provides information about its severity: the higher the blood level of NT-proBNP, the more serious the condition. The suitability of the NT-proBNP assay for a range of indications has now been confirmed by research data. The marker has additional potential in emergency diagnosis, as shown recently by a study group at the Hospital de Sant SANT South African Native Trust Pau in Barcelona who investigated 64 patients with acute dyspnoea dyspnoea dyspnea. (1). The results of the study confirm the suitability of NT-proBNP as an efficient marker in emergency diagnosis, both for excluding and detecting ventricular dysfunction. "Elecsys (R)proBNP is an innovative immunodiagnostic immunodiagnostic pertaining to diagnosis by immune reactions. test which significantly improves the diagnosis of patients suffering from heart failure ", according to Burkhard Piper, head of Centralized Diagnostics. The automated, standardized test method, which is based on electrochemiluminescence, delivers a result in just 18 minutes. Collecting a blood sample is easy and independent of any physical activity and fluctuations occuring during the day. No dietary preparation is necessary. Due to the markers stability, samples can be stored for long periods and dispatched without any problems. (1) E. Zapico-Muniz, M. Santalo-Bel, L. Lopez, C. Cotes, S. Benito, A. Bayes-Genis, J. Ordonez-Llanos; Hospital de la Santa Creu i Sant Pau, Barcelona, SPAIN. Identification of heart failure by amino terminal brain natriuretic natriuretic /na·tri·uret·ic/ (-ur-et´ik) 1. pertaining to, characterized by, or promoting natriuresis. 2. an agent that promotes natriuresis. na·tri·u·ret·ic adj. pro-peptide (NTproBNP) measurements in patients with acute dyspnea dyspnea /dysp·nea/ (disp-ne´ah) labored or difficult breathing.dyspne´ic paroxysmal nocturnal dyspnea . The DAPIC DAPIC Design API Coalition Study; Poster at the AACC AACC American Association of Community Colleges (formerly American Association of Junior Colleges) AACC American Association for Clinical Chemistry AACC American Association of Cereal Chemists AACC Anne Arundel Community College , 20-24 July 2003. About Roche and Roche Diagnostics Headquartered in Basel, Switzerland, Roche is one of the world's leading innovation-driven healthcare groups. Its core businesses are pharmaceuticals and diagnostics. Roche is number one in the global diagnostics market, the leading supplier of pharmaceuticals for cancer and a leader in virology virology, study of viruses and their role in disease. Many viruses, such as animal RNA viruses and viruses that infect bacteria, or bacteriophages, have become useful laboratory tools in genetic studies and in work on the cellular metabolic control of gene expression and transplantation. As a supplier of products and services for the prevention, diagnosis and treatment of disease, the Group contributes on a broad range of fronts to improving people's health and quality of life. Roche employs roughly 65,000 people in 150 countries. The Group has alliances and research and development agreements with numerous partners, including majority ownership interests in Genentech and Chugai. Roche's Diagnostics Division, the world leader in in-vitro diagnostics with a uniquely broad product portfolio, supplies a wide array of innovative testing products and services to researchers, physicians, patients, hospitals and laboratories world-wide. For further information, please visit our websites www.roche.com and www.roche-diagnostics.com. +++ Please register for our convenient "NewsFlash" service in our online "Press Lounge" +++ see our Website "www.roche-diagnostics.com" +++ |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion